• Activity INFORMATION

  Overview

  In a podcast style discussion, Mike Corvino, PharmD and Cole Swanson, PharmD review the management of allergic rhinitis. This common, seasonal illness effects many patients with comorbidities and who are otherwise healthy. Pharmacists and nurses encounter these patients frequently and should be able to recognize characteristics that may differentiate the symptoms from other illnesses. It is important that pharmacists and nurses understand the appropriate use of medications used to treat allergic rhinitis and safety precautions to be aware of. This session seeks to explore these topics, focusing on how this information can best be incorporated into daily medical practice.

  Access the original podcast here.

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify available first-line treatment options for allergic rhinitis

  Identify side effects and risks associated with sedating antihistamines

  Evaluate comparative safety and efficacy of oral antihistamines and glucocorticoid nasal sprays

  Identify agents that are safe to use in special populations for symptom management

  Nurse

  Evaluate comparative safety and efficacy of oral antihistamines and glucocorticoid nasal sprays

  Identify side effects and risks associated with sedating antihistamines

  Identify available first-line treatment options for allergic rhinitis

  Identify agents that are safe to use in special populations for symptom management

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-906468

  Universal Activity Number

  Pharmacist 0798-0000-22-122-H01-P
  Nurse 0798-0000-22-122-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).